Dave Rosa
2022
In 2022, Dave Rosa earned a total compensation of $1.2M as Chief Executive Officer and President at NEUROONE MEDICAL TECHNOLOGIES Corp, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,974 |
|---|---|
| Salary | $472,436 |
| Stock Awards | $525,000 |
| Total | $1,186,410 |
Rosa received $525K in stock awards, accounting for 44% of the total pay in 2022.
Rosa also received $189K in non-equity incentive plan and $472.4K in salary.
Rankings
In 2022, Dave Rosa's compensation ranked 2,659th out of 5,505 executives tracked by ExecPay. In other words, Rosa earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,659 out of 5,505 | 52nd |
Division Manufacturing | 1,471 out of 2,984 | 51st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 175 out of 458 | 62nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 115 out of 325 | 65th |
Industry Surgical and Medical Instruments and Apparatus | 95 out of 239 | 60th |
Source: SEC filing on January 27, 2023.
Rosa's colleagues
We found two more compensation records of executives who worked with Dave Rosa at NEUROONE MEDICAL TECHNOLOGIES Corp in 2022.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021